BrightSpring Stock And 2 Healthcare Picks Tied To Home Based Care Demand

Healthcare is under pressure from every angle right now, from medical students carrying over $590,000 in debt to physicians stepping into roles with salaries that can reach $700,000. That mix of high education costs, strong earnings potential and steady hospital demand is shaping where money flows in the sector. It touches everything from hospital operators to staffing providers and groups focused on healthcare equality. This article looks at how that backdrop connects to 3 stocks exposed to these trends and why you might want to study them more closely before making your next move.

BrightSpring Health Services (BTSG)

Overview: BrightSpring Health Services is a US healthcare platform that provides home and community based pharmacy and clinical care to Medicare, Medicaid and commercially insured patients, from infused and specialty drugs to home health, rehab and behavioral services.

Market Cap: US$15.2b

BrightSpring Health Services sits in the path of several themes from the Healthcare Sector screener, including demand for home based care, specialty pharmacy services and dependable staffing. Analysts expect earnings and revenue growth, while recent results showed higher revenue, raised full year guidance and progress reducing net debt, alongside inclusion in the S&P 400 index and multiple analyst target upgrades in July 2026. At the same time, the company carries meaningful debt and is exposed to government reimbursement and interest rate risk, so funding costs and policy changes matter. If you are looking for a business that is positioned to benefit from growing healthcare employment and specialty treatments, BrightSpring is one worth understanding in more depth.

BrightSpring’s expanding home based care platform, rising revenue and index inclusion suggest a bigger story that many investors may be only half seeing. Get the context, the debt picture and the policy sensitivities in the analysis report for BrightSpring Health Services

InnovAge Holding (INNV)

Overview: InnovAge Holding runs a network of Program of All Inclusive Care for the Elderly, wrapping primary care, in home support, transport and specialist services around frail seniors so they can stay in their own homes rather than move into nursing facilities.

Operations: InnovAge generates about US$948.7m of its roughly US$949.2m revenue from its PACE operations, all in the United States.

Market Cap: US$1.6b

InnovAge Holding operates at the intersection of rising healthcare demand and pressure to control costs. This positioning makes its PACE model notable for those interested in how value based care could influence seniors health. The company is still reporting losses and faces higher external provider costs, regulatory scrutiny and extra spending tied to new center openings, so execution on cost control and compliance is important. Analysts have published expectations of stronger earnings over time, management has raised revenue guidance for fiscal 2026, and a new President and COO with multi state experience has stepped in to focus on operations. For investors tracking healthcare staffing pressures, reimbursement risk and trends in home based care, there are multiple operational and strategic factors to consider beyond the headline losses.

InnovAge’s PACE model sits at the intersection of rising seniors care demand and cost control pressure, yet many investors may miss how the story could evolve. Get the fuller picture in the analyst forecasts for InnovAge Holding

Nanosonics (ASX:NAN)

Overview: Nanosonics is an infection prevention company that designs and sells ultrasound probe disinfection systems and related consumables, along with software that helps hospitals track and manage infection control workflows across multiple regions worldwide.

Operations: Nanosonics generates about A$207.3m in revenue from healthcare equipment, with around A$189.0m from North America, A$12.6m from Europe, the UK and Middle East, and A$5.7m from Asia Pacific.

Market Cap: A$925.0m

Nanosonics sits at the heart of hospital infection control, supplying automated disinfection devices and consumables that support day to day procedures when healthcare demand is strong and safety expectations are high. Analysts have published double digit earnings growth forecasts and some fair value estimates that are materially above the current share price, yet the stock trades on a high P/E and depends heavily on capital spending decisions in hospitals that are facing budget and staffing strain. New platforms like CORIS and fresh IP, paired with recurring consumable and software revenue, make the story more than a single product bet. The key consideration for investors is how that potential compares with margin pressure, regulatory costs and capital budget limits that management has highlighted in recent calls.

Nanosonics’ growth story and hospital exposure can look out of sync. The real question is how its new platforms and recurring revenue stack up against that high P/E. Start with the analyst forecasts for Nanosonics

The three stocks in this article are just a starting point, with the full Healthcare Sector screener surfacing 16 more healthcare services and staffing companies that carry equally compelling narratives. Use Simply Wall St to analyze these stocks side by side, identify the specific catalysts that matter to you, and filter for the highest conviction ideas in this healthcare theme.

Take Control of Your Investment Journey

If BrightSpring Health Services or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Healthcare?

Fresh opportunities do not wait. Stocks can be breaking out, momentum can be building or dropping, and under the radar for now can vanish before the crowd arrives. Investors should act based on their own research and timing.

• Catch potential turnarounds early by scanning curated companies in the 19 high quality undiscovered gems before they are widely talked about and the best entry points are harder to find.
• Explore structural themes in infrastructure by checking stocks in the 35 power grid technology and infrastructure stocks where grid upgrades and reliability spending already sit at the center of long term capital plans.
• Evaluate income potential by focusing on companies in the 9 dividend fortresses that pair stronger balance sheets with higher yields that many investors may overlook.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com